Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome : the EVERE2ST-HIV study

Publié dans European Heart journal. 2017 Jun; 38(21):1676-1686 Auteurs : Hauguel-Moreau M, Boccara F, Boyd A, Salem JE, Brugier D, Curjol A, Hulot JS, Kerneis M, Galier S, Cohen A, Montalescot G, Collet JP, Silvain J. Article disponible en consultant le site Abstract Background and aim : To explore platelet reactivity on dual antiplatelet therapy…

Safety and efficacy of IIb/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes : A meta-analysis of pivotal trials

Publié dans Platelets 2017 Mar;28(2):174-181 Auteurs : Roule V, Agueznai M, Sabatier R, Blanchart K, Lemaitre A, Ardouin P, Collet JP, Milliez P, Montalescot G, Beygui F. Article disponible en consultant le site Abstract The risk and benefit of GP-IIb/IIIa Inhibition (GPI) in combination with recent antiplatelet regimens in acute coronary syndromes (ACS) remain unassessed.…

Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention : An Analysis of the Randomized ATOLL Trial

Publié dans Angiology. 2017 Jan;68(1):29-39 Auteurs : Liu Z, Silvain J, Kerneis M, Barthélémy O, Payot L, Choussat R, Sabouret P, Cohen M, Pollack CV Jr, Goldstein P, Zeymer U, Huber K, Vicaut E, Collet JP, Montalescot G. Article disponible en consultant le site Abstract Elderly (≥75 years old) patients with ST-segment elevation myocardial infarction…